Solid Biosciences Inc.
SLDB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $80 | $74 | $155 | $119 |
| Short-Term Investments | $69 | $50 | $58 | $89 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $2 | $3 | $9 |
| Total Curr. Assets | $157 | $130 | $220 | $223 |
| Property Plant & Equip (Net) | $29 | $33 | $39 | $8 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $2 | $2 | $2 |
| Total NC Assets | $31 | $35 | $41 | $10 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $189 | $165 | $260 | $232 |
| Liabilities | – | – | – | – |
| Payables | $4 | $2 | $3 | $4 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $8 |
| Other Curr. Liab. | $9 | $6 | $8 | $3 |
| Total Curr. Liab. | $30 | $15 | $23 | $24 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $21 | $24 | $26 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $24 | $26 | $29 | $2 |
| Total Liabilities | $51 | $38 | $49 | $24 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$783 | -$659 | -$563 | -$477 |
| AOCI | $0 | $0 | -$0 | -$0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $137 | $126 | $212 | $208 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $189 | $165 | $260 | $232 |
| Net Debt | -$80 | -$74 | -$155 | -$119 |